MARKET

CTXR

CTXR

Citius Pharmaceuticals Inc
NASDAQ
0.8408
+0.0402
+5.02%
After Hours: 0.8025 -0.0383 -4.56% 19:56 12/26 EST
OPEN
0.8000
PREV CLOSE
0.8006
HIGH
0.8599
LOW
0.7978
VOLUME
1.33M
TURNOVER
--
52 WEEK HIGH
5.95
52 WEEK LOW
0.6300
MARKET CAP
17.46M
P/E (TTM)
-0.2485
1D
5D
1M
3M
1Y
5Y
1D
Gold Edges Lower; Omeros Shares Jump
Benzinga · 4d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 4d ago
Dow Gains Over 100 Points; US Jobless Claims Decline
Benzinga · 4d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 4d ago
Stock Market Today: Dow Jones, S&P 500 Futures Drop On Christmas Eve Despite Strong Q3 GDP Report—UiPath, AST SpaceMobile, Ramaco Resources In Focus
Benzinga · 4d ago
Citius Pharmaceuticals (CTXR) Surges 22% After Hours — Here's Why
Benzinga · 4d ago
UiPath, Ramaco Resources And 3 Stocks To Watch Heading Into Wednesday
Benzinga · 4d ago
Citius Oncology Inc. reports FY2025 cash and cash equivalents of USD 3.9 million
Reuters · 5d ago
More
About CTXR
Citius Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and prescription products. The Company's FDA approved LYMPHIR candidate is a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell lymphoma. Its late-stage pipeline also includes Mino-Lok, and CITI-002 (Halo-Lido). Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections (CRBSIs) and central line associated bloodstream infections (CLABSIs). Halo-Lido is a topical formulation of halobetasol propionate, a corticosteroid, and lidocaine that is intended for the treatment of hemorrhoids. The Company is also seeking to develop and commercialize the NoveCite mesenchymal stem cells (NC-iMSCs) to treat acute respiratory conditions with a near term focus on ARDS.

Webull offers Citius Pharmaceuticals Inc stock information, including NASDAQ: CTXR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTXR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTXR stock methods without spending real money on the virtual paper trading platform.